Take special care with Granisetron Kabi: The patient must check with the doctor, nurse or pharmacist before using Granisetron Kabi if he/she: is having problems with bowel movements because of a blockage of the gut (intestines).
If the patient has heart problems, is being treated for cancer with a medicine that is known to damage the heart or has problems with levels of salts, such as potassium, sodium or calcium, in the body (electrolyte abnormalities).
If the patient is taking other '5-HT3 receptor antagonist' medicines. These include dolasetron, ondansetron used like Granisetron Kabi in the treatment and prevention of nausea and vomiting. Cases of life-threatening serotonin syndrome have been reported with 5-HT3 receptor antagonist anti-emetics, particularly when given in combination with other serotonergic and/or neuroleptic drugs. Treatment should be discontinued if such events occur and supportive symptomatic treatment should be initiated. If concomitant treatment of Granisetron Kabi with a drug affecting the serotonergic neurotransmitter system is clinically warranted, careful observations of the patient is advised, particularly during treatment initiation and dose increases.
Important information about some of the ingredients of Granisetron Kabi: Sodium: Granisetron Kabi contains 31.5 mg (1.37 mmol) of sodium per maximum daily dose of 9 mg. To be taken into consideration by patients on a controlled sodium diet.
Driving and using machines: Granisetron Kabi is not likely to affect the patient's ability to drive or use any tools or machines.